Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity, Best Practice & Research Clinical Haematology, vol.21, issue.2, pp.177-192, 2008. ,
DOI : 10.1016/j.beha.2008.02.006
Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation, Leukemia, vol.11, issue.12, pp.2462-2468, 2012. ,
DOI : 10.1056/NEJMoa1108188
TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes, Biology of Blood and Marrow Transplantation, vol.18, issue.10, pp.1525-1532, 2012. ,
DOI : 10.1016/j.bbmt.2012.03.013
Graft-versus-host disease, The Lancet, vol.373, issue.9674, pp.1550-1561, 2009. ,
DOI : 10.1016/S0140-6736(09)60237-3
Advances in graft-versus-host disease biology and therapy, Nature Reviews Immunology, vol.69, issue.6, pp.443-458, 2012. ,
DOI : 10.1038/nri3212
TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD, Bone Marrow Transplant, vol.15, pp.99-104, 1995. ,
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival, Blood, vol.112, issue.4, pp.1539-1542, 2008. ,
DOI : 10.1182/blood-2008-02-138867
Association of Serum Interleukin-7 Levels With the Development of Acute Graft-Versus-Host Disease, Journal of Clinical Oncology, vol.26, issue.35, pp.5735-5741, 2008. ,
DOI : 10.1200/JCO.2008.17.1314
Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD, Bone Marrow Transplantation, vol.119, issue.10, pp.1374-1381, 2011. ,
DOI : 10.1038/bmt.2010.300
Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse, Bone Marrow Transplantation, vol.177, issue.10, pp.1546-1552, 2010. ,
DOI : 10.1038/sj.leu.2404892
Diarrhea during the Conditioning Regimen Is Correlated with the Occurrence of Severe Acute Graft-versus-Host Disease through Systemic Release of Inflammatory Cytokines, Biology of Blood and Marrow Transplantation, vol.16, issue.11, pp.1567-1575, 2010. ,
DOI : 10.1016/j.bbmt.2010.05.001
A biomarker panel for acute graft-versus-host disease, Blood, vol.113, issue.2, pp.273-278, 2009. ,
DOI : 10.1182/blood-2008-07-167098
Biomarkers of immune activation to screen for severe, acute GVHD, Bone Marrow Transplantation, vol.103, issue.4, pp.601-604, 2011. ,
DOI : 10.1097/00007890-197410000-00001
Defining the Intensity of Conditioning Regimens: Working Definitions, Biology of Blood and Marrow Transplantation, vol.15, issue.12, pp.1628-1633, 2009. ,
DOI : 10.1016/j.bbmt.2009.07.004
The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients, Gastroenterology, vol.78, pp.764-771, 1980. ,
Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion, Cell, vol.91, issue.4, pp.521-530, 1997. ,
DOI : 10.1016/S0092-8674(00)80438-9
CX3C-Chemokine, Fractalkine-Enhanced Adhesion of THP-1 Cells to Endothelial Cells Through Integrin-Dependent and -Independent Mechanisms, The Journal of Immunology, vol.164, issue.8, pp.4313-4320, 2000. ,
DOI : 10.4049/jimmunol.164.8.4313
CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow, The Journal of Experimental Medicine, vol.156, issue.8, pp.1413-1419, 1998. ,
DOI : 10.1083/jcb.135.3.837
Activated innate immunity and the involvement of CX3CR1???fractalkine in promoting hematuria in patients with IgA nephropathy, Kidney International, vol.82, issue.5, pp.548-560, 2012. ,
DOI : 10.1038/ki.2012.147
Acute graft-versus-host disease: from the bench to the bedside, Blood, vol.114, issue.20, pp.4327-4336, 2009. ,
DOI : 10.1182/blood-2009-06-204669
A Revision of Billingham???s Tenets: The Central Role of Lymphocyte Migration in Acute Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.12, issue.1, pp.2-8, 2006. ,
DOI : 10.1016/j.bbmt.2005.09.015
Preterminal host dendritic cells in irradiated mice prime CD8+ T cell???mediated acute graft-versus-host disease, Journal of Clinical Investigation, vol.109, issue.10, pp.1335-1344, 2002. ,
DOI : 10.1172/JCI0214989
Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells, Science, vol.285, issue.5426, pp.412-415, 1999. ,
DOI : 10.1126/science.285.5426.412
Donor APCs are required for maximal GVHD but not for GVL, Nature Medicine, vol.90, issue.9, pp.987-992, 2004. ,
DOI : 10.1172/JCI200317601
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm, Cell, vol.76, issue.2, pp.301-314, 1994. ,
DOI : 10.1016/0092-8674(94)90337-9
CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease, Blood, vol.111, issue.8, pp.4403-4412, 2008. ,
DOI : 10.1182/blood-2007-06-097287
CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation, Blood, vol.110, issue.12, pp.3827-3832, 2007. ,
DOI : 10.1182/blood-2006-12-061408
Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease, New England Journal of Medicine, vol.367, issue.2, pp.135-145, 2012. ,
DOI : 10.1056/NEJMoa1201248
Tumor necrosis factor-alphaconverting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1), J. Biol. Chem, vol.276, pp.37993-38001, 2001. ,
The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion, Blood, vol.102, issue.4, pp.1186-1195, 2003. ,
DOI : 10.1182/blood-2002-12-3775
Tumor Necrosis Factor-alpha -converting Enzyme Mediates the Inducible Cleavage of Fractalkine, Journal of Biological Chemistry, vol.276, issue.48, pp.44622-44626, 2001. ,
DOI : 10.1074/jbc.M107327200
A new class of membrane-bound chemokine with a CX3C motif, Nature, vol.385, issue.6617, pp.640-644, 1997. ,
DOI : 10.1038/385640a0
NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS, J. Leukoc. Biol, vol.67, pp.577-584, 2000. ,
Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer, Journal of Neuroimmunology, vol.224, issue.1-2, pp.39-44, 2010. ,
DOI : 10.1016/j.jneuroim.2010.05.007
Dual Functions of Fractalkine/CX3C Ligand 1 in Trafficking of Perforin+/Granzyme B+ Cytotoxic Effector Lymphocytes That Are Defined by CX3CR1 Expression, The Journal of Immunology, vol.168, issue.12, pp.6173-6180, 2002. ,
DOI : 10.4049/jimmunol.168.12.6173
Neuronal Fractalkine Expression in HIV-1 Encephalitis: Roles for Macrophage Recruitment and Neuroprotection in the Central Nervous System, The Journal of Immunology, vol.164, issue.3, pp.1333-1339, 2000. ,
DOI : 10.4049/jimmunol.164.3.1333
Fractalkine in Vascular Biology: From Basic Research to Clinical Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.1, pp.34-40, 2004. ,
DOI : 10.1161/01.ATV.0000095360.62479.1F
Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential, Expert Opinion on Therapeutic Targets, vol.48, issue.2, pp.207-219, 2010. ,
DOI : 10.1016/S1074-7613(00)80165-X
CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice, Journal of Clinical Investigation, vol.121, issue.12, pp.4787-4795, 2011. ,
DOI : 10.1172/JCI59150DS1
CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung, Nature Medicine, vol.16, issue.11, pp.1305-1312, 2010. ,
DOI : 10.1038/nm.2253
URL : https://hal.archives-ouvertes.fr/hal-00726050
CX3CR1 drives cytotoxic CD4+CD28??? T cells into the brain of multiple sclerosis patients, 2012) CX(3)CR1 drives cytotoxic CD4(+)CD28, pp.10-19 ,
DOI : 10.1016/j.jaut.2011.11.006
Decreased Th17 and antigen-specific humoral responses in CX3CR1-deficient mice in the collagen-induced arthritis model, Arthritis & Rheumatism, vol.278, issue.5, pp.1379-1387, 2012. ,
DOI : 10.1002/art.34320
Chemokine???Chemokine Receptor CCL2???CCR2 and CX3CL1???CX3CR1 Axis May Play a Role in the Aggravated Inflammation in Primary Biliary Cirrhosis, Digestive Diseases and Sciences, vol.183, issue.2, pp.358-364, 2014. ,
DOI : 10.1007/s10620-013-2920-6
Fraktalkine Produced by Airway Smooth Muscle Cells Contributes to Mast Cell Recruitment in Asthma, The Journal of Immunology, vol.176, issue.3, pp.1860-1868, 2006. ,
DOI : 10.4049/jimmunol.176.3.1860
Inhibition of CX3CL1 (Fractalkine) Improves Experimental Autoimmune Myositis in SJL/J Mice, The Journal of Immunology, vol.175, issue.10, pp.6987-6996, 2005. ,
DOI : 10.4049/jimmunol.175.10.6987
CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone Tropism, Cancer Research, vol.68, issue.6, pp.1715-1722, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-1315
The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma, Cancer Research, vol.68, issue.21, pp.9060-9069, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-1810
Breast Cancer Metastasis: Challenges and Opportunities, Cancer Research, vol.69, issue.12, pp.4951-4953, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-0099
CX3CL1/fractalkine is a novel regulator of normal and malignant human B cell function, Journal of Leukocyte Biology, vol.92, issue.1, pp.51-58, 2012. ,
DOI : 10.1189/jlb.0112035
Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia, Journal of Internal Medicine, vol.33, issue.Suppl 1, pp.512-524, 2014. ,
DOI : 10.1111/joim.12218
Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease, Journal of Clinical Investigation, vol.104, issue.1, pp.49-57, 1999. ,
DOI : 10.1172/JCI6642
Chemokine Receptor CCR5 Mediates AlloImmune Responses in Graft-versus-Host Disease, Biology of Blood and Marrow Transplantation, vol.16, issue.3, pp.311-319, 2010. ,
DOI : 10.1016/j.bbmt.2009.12.002
Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation., Journal of Clinical Investigation, vol.100, issue.4, pp.904-911, 1997. ,
DOI : 10.1172/JCI119606
CD4+ AND CD8+ T CELLS EACH CAN UTILIZE A PERFORIN-DEPENDENT PATHWAY TO MEDIATE LETHAL GRAFT-VERSUS-HOST DISEASE IN MAJOR HISTOCOMPATIBILITY COMPLEX-DISPARATE RECIPIENTS1, Transplantation, vol.64, issue.4, pp.571-576, 1997. ,
DOI : 10.1097/00007890-199708270-00004
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect, Blood, vol.97, issue.9, pp.2886-2895, 2001. ,
DOI : 10.1182/blood.V97.9.2886
Differential use of FasL-and perforinmediated cytolytic mechanisms by T-cell subsets involved in graft-versusmyeloid leukemia responses, Blood, vol.96, pp.1047-1055, 2000. ,
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses, Journal of Clinical Investigation, vol.107, issue.9, pp.1173-1181, 2001. ,
DOI : 10.1172/JCI11517
Th1 and Th17 join forces for acute GVHD, Blood, vol.118, issue.18, pp.4765-4767, 2011. ,
DOI : 10.1182/blood-2011-09-377325
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease, Blood, vol.118, issue.25, pp.6702-6708, 2011. ,
DOI : 10.1182/blood-2011-08-375006